296. From Launch to 20K Users In Under 6 Months: How SheMed Turned Regulation Into Rapid Growth

Cubicle to CEO

Ellen Yin

Entrepreneurship, Business, Marketing

5.0 • 580 Ratings

🗓️ 28 April 2025

⏱️ 50 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

What if making your product harder to access was the secret to increasing demand? That’s the counterintuitive strategy sisters Olivia and Chloe Ferro bet on to catapult their startup SheMed to over 20,000 sign-ups in just a few months. As the UK’s first female-focused GLP-1 program, SheMed entered a crowded weight-loss market—but instead of competing on convenience, they bet on credibility. By requiring mandatory blood tests before prescribing medication, they not only differentiated themselves but uncovered a staggering insight: 99% of applicants had undiagnosed health conditions. The payoff? A 3X surge in inbound leads, a 120% increase in patient sign-ups, and high-trust partnerships with major clinics—all fueled by a safety-first approach that turned medical rigor into a viral growth lever. If you’ve ever worried that implementing stricter client or customer qualifications might slow your sales, this case study is an excellent reminder that trust is your most powerful conversion strategy. Thank you to our sponsor! Get at least 15% off any annual Masterclass membership at https://masterclass.com/cubicletoCEO Connect with Chloe + Olivia: https://⁠shemed.co.uk IG: @shemed_uk TikTok: ⁠@shemed_uk⁠ FB Group: SheMed UK TikTok: @shemed_uk LinkedIn: https://www.linkedin.com/in/chloe-ferro/ LinkedIn: https://www.linkedin.com/in/oliviaferro/ Iconic business leaders all have their own unique genius. Take this quick 10 question quiz to uncover your specific CEO style advantage: ⁠https://cubicletoceo.co/quiz⁠ If you enjoyed today's episode, please: Post a screenshot & key takeaway on your IG story and tag me ⁠@missellenyin⁠ & ⁠@cubicletoce⁠o so we can repost you. Leave a positive review or rating at ⁠www.ratethispodcast.com/cubicletoceo⁠ Subscribe for new episodes every Monday. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	You're listening to Kivocalda CEO, Episode 2.96. What if making your product harder to access
0:05.6	was the secret to increasing demand? That's the counterintuitive strategy. Sisters Olivia and
0:10.9	Chloe Farrow bet on to catapult their startup, SheMed, to over 20,000 signups in just a few months.
0:17.5	As the UK's first female-focused GLP1 program, she med entered a crowded
0:22.8	weight loss market, but instead of competing on convenience, they bet on credibility. By requiring
0:28.3	mandatory blood tests before prescribing medication, they not only differentiated themselves, but uncovered
0:33.9	a staggering insight. Ninety-nine percent of applicants had undiagnosed health conditions.
0:39.0	The payoff?
0:39.9	A 3x surge in inbound leads, a 120% increase in patient signups,
0:44.9	and high trust partnerships with major clinics,
0:47.5	all fueled by a safety first approach that turned medical rigor
0:50.6	into a viral growth lever.
0:52.8	If you've ever worried that implementing stricter client
0:55.6	or customer qualifications might slow your sales, this case study is an excellent reminder that
1:00.6	trust is your most powerful conversion strategy. Welcome to Cubicle to CEO, the podcast where we ask successful founders and CEOs,
1:13.2	the business questions you can't Google.
1:15.8	I'm your host, Ellen Yin.
1:17.6	Every Monday, go behind the business in a case study style interview with a leading entrepreneur
1:22.1	who shares one specific growth strategy they've tested in their own business,
1:27.0	exactly how they implemented it,
1:29.1	and what the results and revenue were. You'll also hear financially transparent insights
1:34.4	from my own journey bootstrapping our media company from a $300 freelance project into millions
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Ellen Yin, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Ellen Yin and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.